Antifungal resistance: current trends and future strategies to combat

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 66%
• Antifungal 33%
• Antifungal Agent 100%
• Aspergillus 33%
• Aspergillus fumigatus 33%
• Candida Albicans 33%
• Drug 33%
• Echinocandin 66%
• Environmental Exposure 33%
• Ergosterol 33%
• Fluconazole 33%
• Fusarium 33%
• Glucan 33%
• Incidence 33%
• Infection 66%
• Mortality Rate 33%
• Mould 33%
• Prevalence 33%
• Pyrrole 100%
• Pyrrole Derivative 33%
• Resistance to Antifungal Agent 66%
• Scedosporium 33%
• Systemic Mycosis 33%
• Toxicity 66%